|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 5, 1484-1500, May 2002

and
*Department of Biology, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02139; and
Department of Cell
Biology, Albert Einstein College of Medicine, Bronx, New York 10461
| |
ABSTRACT |
|---|
|
|
|---|
The Saccharomyces cerevisiae proteins Sec34p and Sec35p are components of a large cytosolic complex involved in protein transport through the secretory pathway. Characterization of a new secretion mutant led us to identify SEC36, which encodes a new component of this complex. Sec36p binds to Sec34p and Sec35p, and mutation of SEC36 disrupts the complex, as determined by gel filtration. Missense mutations of SEC36 are lethal with mutations in COPI subunits, indicating a functional connection between the Sec34p/sec35p complex and the COPI vesicle coat. Affinity purification of proteins that bind to Sec35p-myc allowed identification of two additional proteins in the complex. We call these two conserved proteins Sec37p and Sec38p. Disruption of either SEC37 or SEC38 affects the size of the complex that contains Sec34p and Sec35p. We also examined COD4, COD5, and DOR1, three genes recently reported to encode proteins that bind to Sec35p. Each of the eight genes that encode components of the Sec34p/sec35p complex was tested for its contribution to cell growth, protein transport, and the integrity of the complex. These tests indicate two general types of subunits: Sec34p, Sec35p, Sec36p, and Sec38p seem to form the essential core of a complex to which Sec37p, Cod4p, Cod5p, and Dor1p seem to be peripherally attached.
| |
INTRODUCTION |
|---|
|
|
|---|
In Saccharomyces cerevisiae, COPI and COPII vesicles
shuttle proteins between the endoplasmic reticulum (ER) and the Golgi apparatus (Kaiser et al., 1997
). COPII vesicles are
responsible for most, if not all, biosynthetic protein transport from
the ER to the cis-Golgi, whereas COPI vesicles are the
carriers for retrograde transport of proteins from the Golgi to the ER.
Defects in either COPI or COPII vesicle transport can block ER-to-Golgi transport, possibly because some cargo may need to be retrieved from
the Golgi to the ER for ER-to-Golgi transport to continue (Pelham,
1994
).
The stages of COPII vesicle transport include vesicle formation,
vesicle docking, and vesicle fusion. Vesicle formation occurs by
recruitment of cytosolic complexes onto the ER surface, and results in
the pinching off of protein-coated vesicles enriched with cargo
destined for the Golgi (Barlowe, 1995
). Vesicle docking takes place at
the Golgi, via formation of a physical bridge involving complexes of
integral membrane proteins known as soluble
N-ethylmaleimide-sensitive factor attachment protein
receptors (SNAREs) (Söllner et al., 1993
). In SNARE
complexes, molecules on the vesicle associate with molecules on the
target membrane. Subsequent to SNARE complex formation, vesicle
and Golgi membrane bilayers fuse and the cargo contained in the vesicle
is delivered to the Golgi.
COPII vesicles that have been formed in vitro can attach to the Golgi
even in the absence of the formation of SNARE complexes (Cao et
al., 1998
). This pre-SNARE complex association, called tethering,
is proposed to be a primary, possibly looser, connection between
vesicles and the Golgi (Pfeffer, 1999
; Guo et al., 2000
). A
large number of proteins have been implicated in tethering COPII vesicles, by their effects on vesicle attachment in vitro. These include the multisubunit transport protein particle complex (TRAPP complex), the small GTP-binding protein Ypt1p, the large-coiled coil
protein Uso1p, and a large complex containing the Sec34p and Sec35p
proteins (Cao et al., 1998
; Sacher et al., 1998
;
VanRheenen et al., 1998
, 1999
).
Disruption of either SEC34 or SEC35 causes a
severe growth defect in yeast, and Sec34p is conserved throughout
eukaryotic genomes (VanRheenen et al., 1998
, 1999
; Kim
et al., 1999
; Suvorova et al., 2001
). Therefore,
the Sec34p/Sec35p complex is likely to have an important function in
vesicle-mediated transport. This function is poorly characterized, but
genetic interactions have suggested a functional connection between the
Sec34p/Sec35p complex and both Ypt1p and Uso1p. For instance, the
growth defects of sec34 and sec35 mutants can be
suppressed by overexpression of Ypt1p or Uso1p (VanRheenen et
al., 1998
, 1999
). Furthermore, defects in YPT1,
USO1, SEC34, and SEC35 can all be
suppressed by expression of SLY1-20, a dominant allele of
SLY1, which encodes a regulator of SNARE complexes (Dascher
et al., 1991
; Sapperstein et al., 1996
;
VanRheenen et al., 1998
, 1999
).
Interestingly, SEC34 loss of function alleles were also
isolated in a screen for mutants that mislocalize late Golgi and
vacuolar proteins; SEC34 is the same gene as
GRD20 (Spelbrink and Nothwehr, 1999
). At present, it is not
clear how to reconcile a role for Sec34p in the late secretory pathway
with its proposed role in ER-to-Golgi transport.
In both yeast and mammalian cells, Sec34p exists in a large complex
(Kim et al., 1999
; VanRheenen et al., 1999
;
Suvorova et al., 2001
). Previous work suggested that the
yeast Sec34p/Sec35p complex contains additional unidentified components
(Kim et al., 1999
). Herein, we present the identification
and analysis of three new components of the yeast Sec34p/Sec35p
complex, encoded by the genes SEC36, SEC37, and
SEC38.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and plasmids used in this work are listed in Tables
1 and 2.
|
|
Plasmid Construction and Gap Repair
To make pRR14, an EaeI/KpnI fragment
containing SEC36 was subcloned from a library clone into the
NotI/KpnI sites of pRS316. The same
EaeI/KpnI fragment was inserted into pRS306-2µ
cut with NotI/KpnI, resulting in pRR31. pRR35 was
made in two steps. First, a BamHI site was introduced in
pRR14 just before the first ATG codon of SEC36 by
site-directed mutagenesis, as described in Kunkel et al.
(1987)
, by using the primer
5'-TGGTAGAAAACCTAAAAAAAACCAATACGGATCCAAATGGATGAAGTC-3'. Then, the BamHI/KpnI (with blunt end) fragment
from this construct was ligated into the
BamHI/SacI (with blunt end) site of the
URA3 centromere vector pCD43, placing it just downstream of
the GAL1 promoter.
For integrative mapping of SEC36, a 2.7-kb KpnI/HindIII fragment from sequences flanking the YGL223c open reading frame (ORF) was inserted into pRS306. The resulting plasmid was cut with MluI for integration into the genome by homologous recombination.
pRR55 was made by first polymerase chain reaction (PCR) amplifying SEC36 from pRR14 by using the following primers: primer 1, 5'-AAAAAACCAATACGGATCCAAATGGATGAAGTCTTAC-3'; and primer 2, 5'-ATTATATTACTCGAGCCTTAATTGAGTAATTTGATC-3'. The resulting fragment was digested with BamHI/AvaI and inserted into pET21d (Novagen, Madison, WI) at its BamHI/XhoI sites.
pRR30 was made by first adding a NotI site at the 3' end of the SEC36 coding region in pRR14 through site-directed mutagenesis by using the following primer: 5'-CGATCAAATTACTCAATTACGCGGCCGCTAATATAATAGCACGAGGGA-3'. The resulting plasmid was cut with NotI and ligated to a NotI fragment from pGTEP1, which contains three tandem in-frame hemagglutinin (HA) epitopes.
Plasmids pRR65 and pRR66 were made by PCR amplification of SEC34 and SEC35 with the following primers: SEC34 primer 1, 5'-AACTCTAAGTATCAGCTGCGGCCGCATCATAAGTAGTATTA-AT-3'; SEC34 primer 2, 5'-GAAATTACACATAAGTTTATTGCGCGCTGGTATCAATATCACC-3'; SEC35 primer 1, 5'-GGTATAATGGGATGTGCGGCCGCTTTTATGAGGGTGCCTTA-3'; and SEC35 primer 2, 5'-GAAAGTTTTCTCCCAACTGCGCGCTTTTTATAATGGAGACTA-3'. Resulting fragments were digested with BssHII/NotI and ligated into a vector derived from pRS325 that contains a BssHII fragment encoding three tandem c-myc epitopes. Sec34p-myc and Sec35p-myc proteins expressed from these constructs contain the following amino acid residues at the junctions with their epitope tags: Sec34p-myc, ... GDIDTSAPEQKLISEEDLN... ; Sec35p-myc, ... LVSIISAPEQKLISEEDLN...
To make plasmid pRR72, SEC38 was PCR amplified with the
following primers: primer 1, 5'-TATAGTGAAGGATCCAAGCAACTTTTGAAACACATTTAC-3'; and primer
2, 5'-TATAGTGAAGGAGGTACCCAACTTTTGAAACACATTTAC-3'. The resulting fragment was digested with BamHI and
KpnI and ligated into pRS426 at its
BamHI/KpnI sites. Gap repair of
sec36-1 was performed using a variant of pRR14 that was cut
with HpaI/EcoRI (Orr-Weaver et al.,
1983
).
Identification of sec34-3
A centromeric plasmid expressing SEC34 was constructed by ligating a SphI fragment from a YCp50 library clone into the SmaI site of the vector pRS316. The only genes in this resulting plasmid were SEC34 and the tRNA-Glu gene. Removal of a BstEII/BglII fragment internal to SEC34 abolished the ability of this construct to rescue the temperature-sensitive (ts) growth of strain 394ts. To show that the mutation in strain 394ts was at the SEC34 locus, a 2.7-kb XhoI/SpeI fragment near the SEC34 gene was ligated into pRS306, and this plasmid was cut with HindIII. This fragment was integrated by homologous recombination into the genome of a wild-type strain, which was then mated to the 394ts strain. After sporulation, 14/14 tetrads showed cosegregation of Ts+ and Ura+ phenotypes.
Gas1p, Carboxypeptidase Y (CPY), and Invertase Pulse-labeling and Immunoprecipitation
Transport assays by radiolabeling and immunoprecipitation were
done as described in Gimeno et al. (1995)
. For Gas1p and CPY assays, radiolabeled extracts from 1 OD600 units
of cells were incubated with 1 µl of either Gas1p antibody or CPY
antibody. After washes, the entire immunoprecipitate was loaded onto a
gel. For internal versus secreted invertase immunoprecipitations,
strains with invertase expressed from the TPI promoter were
used to circumvent the need to induce invertase production in low
glucose. Invertase expressed in this way was transported like wild-type
secreted invertase (our unpublished data). For each experiment, 2 OD600 units of cells were labeled for 10 min, and
converted to spheroplasts by using lyticase. Spheroplasts were
centrifuged at 500 × g for 5 min. Resulting
supernatant and pellet fractions were resuspended in 1 ml of
immunoprecipitation buffer before incubation with 1 µl of invertase
antibody. Immunoprecipitates were then processed for SDS-PAGE as
described in Gimeno et al. (1995)
.
Disruption of SEC36, SEC37, and SEC38
The following primers were used to amplify kanMX6 flanked by sequences adjacent to the YGL223c ORF, used to disrupt SEC36 by homologous recombination: primer 1, 5'-CAACAAATCTTGTGGTAGAAAACCTAAAAAAAACCAATACGATAGAAACGTACGCTGCAGGTCGAC-3'; and primer 2, 5'-CATTATCAATAAGTTTGCGAGGCGGGTACCCTCCCTGTGCTATTATAGAATTCGAGCTCGTTTAAAC-3'. sec37 and sec38 null strains were obtained from EUROSCARF (www.uni-frankfurt.de/fb15). Fragments containing the disrupted loci were PCR amplified with primers to flanking sequences and transformed into the S288C genetic background to generate CKY733, CKY734, CKY735, and CKY736.
Protein Extracts and Cell Fractionation
Whole-cell extracts were prepared by resuspending 2 OD600 units of cells in 30 µl of sample buffer
(60 mM Tris-Cl pH 6.8, 2% SDS, 100 mM dithiothreitol [DTT], 10%
glycerol, and 0.001% bromphenol blue), boiling for 1 min, and lysing
by agitation with glass beads. An additional 70 µl of sample buffer
was added before 30 µl of the supernatants was analyzed by SDS-PAGE.
Cell fractionation was performed as described in Espenshade et
al. (1995)
.
Sec36p Antibody Production and Immunoblotting
Plasmid pRR55 was transformed into BL21(DE3) bacteria (Novagen). Transformants were grown overnight at 24°C in 2XYT medium with antibiotics. Induction was not necessary for fusion protein production. Cells were resuspended and sonicated. Insoluble Sec36p-His6 was pelleted by centrifugation and resuspended in 6 M guanidine hydrochloride. Guanidine was removed by dialysis, resulting in precipitation of the fusion protein. The precipitate was harvested by centrifugation and solubilized in sample buffer. Recovered protein was run out by SDS-PAGE, Coomassie stained, and used to prepare polyclonal antibodies in rabbits by standard protocols at Covance. Sec36p antibodies were affinity purified using fusion protein immobilized on nitrocellulose membranes, and eluted with 100 mM glycine, pH 2.5. Antibodies were used at the following dilutions for immunoblotting: anti-invertase at 1/1000, anti-CPY at 1/1000, anti-glutathione S-transferase (sc-459; Santa Cruz Biotechnology, Santa Cruz, CA) at 1/1000, affinity-purified anti-Sec36p at 1/500, affinity-purified anti-Sec34p at 1/1000, and affinity-purified anti-Sec35p at 1/500. Horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ) were used at 1/3000.
Sec34p-myc, Sec35p-myc, and Sec36p Coimmunoprecipitation Experiments
Sec34p-myc and Sec35p-myc
immunoprecipitations were done by a variation of the protocol for
Sec35p-myc immunoprecipitations of Kim et al.
(1999)
. Cells were grown to an OD600 of 0.5-1.5. For each experiment, 10 OD600 units of cells were
collected by centrifugation, washed, and resuspended in buffer D (20 mM
HEPES pH 7.2, 1% Triton X-100, 150 mM KCl, 0.5 mM DTT, 2 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride). Samples were lysed with glass beads,
and 850 µl of buffer D was added per tube before centrifugation for 1 min at 12,000 × g. The cleared supernatant was
transferred to a 1.5-ml ultracentrifuge tube, and centrifuged for 30 min at 100,000 × g in a TLS55 rotor (Beckman
Coulter, Fullerton, CA). The supernatant from this
centrifugation was adsorbed with protein A-Sepharose. After removal of
protein A-Sepharose, the supernatant was incubated with 5 µl of
c-myc antibody (9E10) overnight at 4°C. Immune complexes
were collected by incubation with protein A-Sepharose for 1 h at
4°C. Immunoprecipitates were washed three times with buffer D and
three times with buffer E (same as buffer D, but with 500 mM KCl), and
then resuspended in sample buffer, before SDS-PAGE. For radiolabeled
Sec36p and Sec35p-myc immunoprecipitations, 10 OD600 units of cells were first labeled for
3 h in medium lacking methionine with 200 µCi of
35S Express label (PerkinElmer Life Sciences,
Boston, MA), and then immunoprecipitations were performed as described
above, with either 5 µl of affinity-purified Sec36p antibody or 5 µl of 9E10 antibody.
Partial Purification of Sec34p/Sec35p/s36p
Yeast strains were grown at room temperature to an
OD600 of 3-4. Then 12,000 OD600 units of cells were collected by
centrifugation, and processed similarly to methods described in
VanRheenen et al. (1999)
, with the following modifications.
The only protease inhibitor added was 1 mM phenylmethylsulfonyl
fluoride. Cells were resuspended in 100 ml of lysis buffer, and lysed
in a bead beater (Biospec Products, Bartlesville, OK). Lysed sample was pelleted for 20 min at 20,000 × g in a SS34 rotor
(Beckman Coulter), and the supernatant was transferred to a SW28 rotor
(Beckman Coulter), where it was centrifuged for 2 h at
100,000 × g. The supernatant was passed through a
0.45-µm syringe filter. To 36 ml of the filtrate, saturated ammonium
sulfate solution was added dropwise to a final concentration of 40%.
Anion exchange chromatography was performed with a 16-ml CL-6B
DEAE-Sepharose column (1.5 cm i.d.; Pharmacia, Peapack, NJ). Samples
were bound in buffer containing 100 mM KCl and eluted with a gradient
of KCl from 100 to 400 mM. Fractions containing Sec36p-HA were
identified by immunoblotting with HA antibody (12CA5).
Then, 500 µl of the Sec36p-HA elution was loaded onto a 24-ml
Superose 6 gel filtration column (HR10/30; Pharmacia) preequilibrated
in 190 mM KCl, 25 mM Tris-Cl pH 8.0, and 1 mM DTT. The column was run
at 0.4 ml/min, and 0.4-ml fractions were collected. Aliquots were
trichloroacetic acid (TCA) precipitated and analyzed by SDS-PAGE and immunoblotting.
Gel Filtration of Whole-Cell Extracts
Yeast cultures were grown to the exponential phase at 24°C, after which 400 OD600 units of cells were collected and converted to spheroplasts by treatment with lyticase. Because the sec38::kanMX4+SLY1-20 strain grows very slowly, it was inoculated into successively larger cultures for almost 2 wk to obtain enough cells for this experiment. Spheroplasts were Dounce homogenized in 1.5 ml of 190 mM KCl, 25 mM Tris-Cl pH 8.0, and 1 mM DTT; centrifuged briefly to pellet unlysed cells; and centrifuged again for 30 min at 100,000 × g in a TLS55 rotor (Beckman Coulter). Supernatant from this sample was passed through a 0.45-µm syringe filter. Then, 500 µl of the filtrate was applied to a Superose 6 gel filtration column (HR10/30; Pharmacia) that was preequilibrated with 190 mM KCl, 25 mM Tris-Cl pH 8.0, and 1 mM DTT. The column was run at 0.4 ml/min, and 0.8-ml fractions were collected. Aliquots were TCA precipitated and analyzed by SDS-PAGE and immunoblotting. Protein levels were quantitated using Kodak ImageStation software (Eastman Kodak, Rochester, NY).
Large-Scale Sec35p-myc Coimmunoprecipitations and Mass Spectrometry
Yeast cultures were grown at 24°C to an
OD600 of 3-4. Then, 12,000 OD600 units of cells were collected by
centrifugation. Cells were resuspended in 100 ml of buffer D and lysed
in a bead beater (Biospec Products). Lysed sample was pelleted for 20 min at 20,000 × g in a SS34 rotor (Beckman Coulter),
and the supernatant was transferred to a SW28 rotor (Beckman Coulter),
where it was centrifuged for 2 h at 100,000 × g.
The supernatant was passed through a 0.45-µm syringe filter. Filtrate
(30 ml) was incubated for 3-4 h with 3 mg of purified c-myc
antibody (9E10) conjugated to Sepharose beads (Covance) that had been
washed in 100 mM glycine pH 2.5, washed in buffer E, and equilibrated
in buffer D. Samples were then transferred to a disposable glass column
(Bio-Rad, Hercules, CA), where they were washed with 30 ml of buffer D,
and 30 ml of buffer E. Bound material was eluted with 100 mM glycine pH 2.5, and 0.5-ml fractions were collected. Fractions containing Sec36p,
as determined by immunoblotting, were TCA precipitated and pooled in sample buffer. The cell lysate was reimmunoprecipitated with the same batch of antibody-conjugated Sepharose beads and both
sets of elution pools were combined and loaded into a single gel lane.
After SDS-PAGE, gels were stained with Coommassie blue, and gel
fragments were excised. Samples were subjected to in-gel trypsin
digests and the resulting peptides were analyzed by matrix-assisted laser desorption ionization mass spectrometery at the Massachusetts Institute of Technology Biopolymers Laboratory. Peptide masses were
examined using the MS-FIT algorithm of the Protein Prospector program
(Clauser et al., 1999
). One missed cleavage was allowed, and
significant matches required more than two matching peptides and MOWSE
scores >104.
| |
RESULTS |
|---|
|
|
|---|
sec36-1 Mutation Blocks Transport of Several Proteins through the Secretory Pathway
In a genetic screen for mutants defective in ribosome synthesis,
temperature-sensitive strains were isolated that seemed to be primarily
impaired in transport of secretory proteins (Mizuta and Warner, 1994
;
Li and Warner, 1996
). One of these mutants, 271ts, showed accumulation
of the secreted protein CPY in its ER-modified p1 form at 37°C,
indicating a defect in transport between the ER and medial Golgi
compartment (Li and Warner, 1996
). When strain 271ts was backcrossed
four times to the S288C strain background, temperature sensitivity and
the CPY transport defect cosegregated as a single nuclear gene mutation
(our unpublished data). We have designated the affected gene
SEC36, and the altered allele found in strain 271ts
sec36-1.
To test whether sec36-1 caused a general transport defect,
we evaluated the transport of two other secretory proteins: Gas1p and
invertase. Gas1p, a glycophosphatidylinositol-modified plasma membrane protein, acquires polysaccharide modifications in the Golgi,
where it matures from a 105-kDa protein to a 125-kDa species. At the
cell surface, Gas1p can be degraded by extracellular proteases (Sütterlin et al., 1997
), so we studied strains that
contain the sec6-4 mutation, which prevents transport of
proteins from the Golgi to the plasma membrane (Potenza et
al., 1992
), to monitor Gas1p maturation without the complication
of cell surface proteolysis. In pulse-chase experiments, the
sec6-4 mutant exhibited significant processing of Gas1p to
the 125-kDa species after 15 min at 38°C (Figure
1A). In contrast, the sec6-4
s36-1 double mutant strain exhibited no maturation of Gas1p in 15 min at 38°C (Figure 1A), indicating that sec36-1 blocks
Gas1p maturation.
|
The secretory protein invertase becomes hyperglycosylated during
transport through the Golgi (Novick and Schekman, 1983
). In wild-type
yeast, invertase matures to a heterogeneous array of 100-150-kDa
bands. In a sec36-1 mutant, invertase migrated as a species
smaller than 100 kDa, suggesting that it received less outer chain
glycosylation that normal (Figure 1B). Furthermore, a significant
portion of invertase was blocked in its secretion to the periplasm and
accumulated intracellularly (Figure 1B). Collectively, these results
indicate that the sec36-1 mutation causes a general block in
secretory protein traffic at the restrictive temperature. However,
invertase received more outer chain glycosylation in the
sec36-1 mutant than in the ER-to-Golgi transport mutant sec12-4 (Figure 1B), suggesting that the block in transport
occurred after invertase had passed through early Golgi compartments.
SEC36 Is in a Previously Uncharacterized ORF
To isolate the SEC36 gene, the pCT3 and YCp50
centromere-based yeast genomic DNA libraries (Rose et al.,
1987
; Thompson et al., 1993
) were screened for clones that
complement the inviability of the sec36-1 strain at 38°C.
Five plasmids were identified that complemented both the CPY transport
defects and temperature-sensitive growth defects. Each contained a 5-kb
segment from the left arm of chromosome VII. Removal of a 700-bp
AflII fragment internal to the YGL223c ORF on these library
plasmids abolished their ability to complement the growth defects of a
sec36-1 mutant (our unpublished data). Conversely, a plasmid
containing only the YGL223c coding region expressed from the
pGAL1 promoter (pRR35) restored growth to a
sec36-1 strain at restrictive temperatures (our unpublished data).
To verify that YGL223c is at the sec36-1 locus, we integrated the URA3 marker by homologous recombination into chromosome VII, immediately adjacent to YGL223c. When this integrant was crossed to a sec36-1 mutant strain, the URA3 marker segregated with Ts+ in all 14 tetrads analyzed, showing that this region is tightly linked to the SEC36 locus.
SEC36 Encodes a Novel Protein That Is Truncated in sec36-1 Mutants
SEC36 encodes an acidic 417 amino acid protein that is ~48 kDa. This was predicted by sequence analysis and confirmed by the demonstration that affinity-purified Sec36p antibody recognized a 50-kDa protein species in yeast lysates (Figure 1C). A nucleotide sequence was identified by the Génolevures project (http://cbi.labri.u-bordeaux.fr/Genolevures/Genolevures.php3) that may code for a Sec36p homolog in the budding yeast species Saccharomyces exiguus. Using the National Center for Biotechnology Information BLASTX algorithm, the translation product of this DNA fragment was shown to have 29% identity over a 231-amino acid region of Sec36p. No other sequences with significant similarities to the Sec36p amino acid sequence were found.
To define the mutation responsible for the defects in
sec36-1, we used the gap repair method (Orr-Weaver et
al., 1983
), by which a segment of the SEC36 locus on a
centromeric plasmid was excised, transformed into a sec36-1
mutant, and repaired by homologous recombination. The base sequence of
the gap-repaired plasmids revealed a point mutation at position 594 (G
to A), which converts the codon for Trp198 to a stop codon (Figure 1D).
This mutation created a truncated gene product of about half the size
of wild-type Sec36p that could be detected by immunoblots
of lysates from sec36-1 mutant cells (Figure 1C).
Disruption of SEC36 Leads to a Severe Growth Defect
A disruption of the SEC36 locus was constructed by replacement of the YGL223c ORF in a wild-type diploid strain with kanMX6. Tetrads formed after sporulation of this diploid were dissected and grown at temperatures ranging from 18 to 37°C. The spore clones that carried that sec36::kanMX6 disruption formed only microcolonies at each temperature (our unpublished data). Identical results were obtained when a 700-base pair region after the first 11% of the YGL223c ORF was replaced by the TRP1 gene (our unpublished data). Viable spores containing sec36 disruptions could be recovered when wild-type SEC36 on a URA3-CEN plasmid is also present (our unpublished data). Unlike sister spores lacking the disruption, these cells were inviable on plates containing 5-fluoroorotic acid, showing their dependence on SEC36 for vigorous growth (our unpublished data). The observation that the C-terminal truncations caused by the sec36-1 mutation produced a much less severe growth defect than a complete gene deletion suggests that the N terminus of Sec36p is sufficient for its activity in the cell at most physiological temperatures.
Synthetic Lethality between sec36-1 and Mutations in COPI Coat Subunits and in Vesicle-docking and Fusion Proteins
To identify the stage of vesicle transport that is affected by
sec36-1, we crossed cells containing the sec36-1
mutation to strains with previously characterized secretory pathway
blocks, and examined the meiotic progeny that resulted from sporulation of these diploids. It has been observed that mutations that impair the
same stage of vesicle transport often display synthetic lethality, where the combinations of mutations are far more detrimental than the
effect of each mutation on its own (Kaiser and Schekman, 1990
). As
shown in Figure 2, the sec36-1
allele displayed only weak synthetic interactions with COPII vesicle
formation mutations and Golgi-to-plasma membrane transport mutations.
In contrast, it displayed severe synthetic growth defects with several
vesicle docking and fusion mutations such as sec17-1 and
sly1-ts, as well as with all four of the COPI coat protein
mutations tested. These data suggest that the function of
SEC36 may be closely tied to both vesicle docking and fusion
as well as COPI function.
|
Sec36p Is in a Large Cytosolic Complex
To localize Sec36p, we used yeast cells containing Sec36p tagged
at the C terminus with three HA epitopes as the only source of Sec36
protein. Spheroplasts from this strain were fractionated by
differential centrifugation, and probed with monoclonal antibody to the
HA epitope (12CA5). As shown in Figure
3A, Sec36p-HA was predominantly
cytosolic. Similar results were obtained with wild-type extracts probed
with Sec36p antibody (our unpublished data).
|
To determine the size of native Sec36p, cytosolic samples from the strain containing Sec36p-HA were first precipitated with 40% ammonium sulfate and further purified over a DEAE-Sepharose anion exchange column. The pooled fractions containing Sec36p-HA were applied to a Superose 6 gel filtration column. Fractions from the Superose 6 column were analyzed by immunoblotting with HA antibody (12CA5). Fractions containing Sec36p-HA eluted from the Superose 6 column before the 670-kDa thyroglobulin marker (Figure 3B), placing Sec36p in a cytosolic complex with an estimated molecular mass of ~800 kDa. The same gel filtration profile was observed when samples from wild-type cells were analyzed with Sec36p antibody (our unpublished data).
Sec36p Coimmunoprecipitates with Sec34p-myc and Sec35p-myc
The yeast proteins Sec34p and Sec35p were recently found to reside
in a large cytosolic complex involved in tethering ER-derived vesicles
to the cis-Golgi (Kim et al., 1999
; VanRheenen
et al., 1999
). Because the sec36-1 mutant
displayed characteristics of a vesicle-docking or fusion defect, we
surmised that Sec36p might be in the Sec34p/Sec35p complex. Consistent
with this hypothesis, we found that endogenous Sec36p efficiently
coimmunoprecipitated with both Sec34p-myc and
Sec35p-myc (Figure 4). In the
absence of tagged versions of either Sec34p or Sec35p, Sec36p was not immunoprecipitated, indicating that Sec36p formed a specific, direct or
indirect, association with these proteins. The Sec36-1p protein,
produced by a strain containing the sec36-1 mutation, did
not efficiently interact with either Sec34p-myc or
Sec35p-myc under these conditions (our unpublished data).
|
Effects of sec36-1 and sec35-1 on Size of Complex Containing Sec34p, Sec35p, and Sec36p
As shown in Figure 5A, when yeast
cell lysates were fractionated on a Superose 6 gel filtration column,
Sec34p, Sec35p, and Sec36p exactly coeluted, consistent with all three
proteins residing in the same complex. Based on these experiments, the
apparent size of this complex is >800 kDa, which is larger than the
size estimated from gel filtration analysis of lysates that were first precipitated with ammonium sulfate and fractionated by anion exchange chromatography (VanRheenen et al., 1999
; Figure 3B).
|
To explore the relationship among Sec34p, Sec35p, and Sec36p further,
we monitored the migration of these proteins through a Superose 6 gel
filtration column during fractionation of extracts from cells
containing either a sec36-1 or sec35-1 mutation.
We found that when cytosol from a sec36-1 mutant was
fractionated on the Superose 6 column, Sec34p and Sec35p still
comigrated, but eluted later than from wild-type extracts, indicating
that the size of the Sec34p/Sec35p complex had been altered by
sec36-1 (Figure 5, B and C). Likewise, when whole-cell
cytosol from a sec35-1 mutant was fractionated by Superose 6 chromatography, Sec36p eluted much later than from wild-type extracts
(Figure 6), suggesting that the complex
in which Sec36p normally resides had been drastically altered by
sec35-1. These results strongly suggest that Sec34p, Sec35p,
and Sec36p are components of the same cytosolic complex. Moreover, they
imply that disruption of this complex is the likely cause for the in
vivo growth defects observed in strains containing either the
sec35-1 or the sec36-1 mutation.
|
Genetic Evidence for a Functional Link between Sec34p, Sec35p, and Sec36p
To evaluate whether Sec36p functions with Sec34p and Sec35p in
cells, we analyzed the genetic relationships between SEC34, SEC35, and SEC36. VanRheenen et al.
(1999)
reported that the growth defects of strains containing
sec34-1 and sec35-1 mutations were suppressed by
the SLY1-20 dominant allele on a low copy number plasmid. We
found that this plasmid efficiently suppressed the growth defect of a
sec36-1 mutant as well (Figure
7A), and partially suppressed the
inviability of sec36::kanMX6 cells to the same extent that it partially suppressed the inviability of sec34
and sec35 null cells (Figure 7B; VanRheenen et
al., 1998
, 1999
). Furthermore, as reported for overexpression of
Sec34p, overexpression of Sec36p was found to partially suppress the
sec35-1 mutation (Figure 7C; Kim et al., 1999
).
However, overexpression of Sec34p or Sec35p did not affect the growth
of sec36-1 strains (Figure 7A).
|
Loss of function alleles of SEC34 and SEC35 are
each temperature sensitive for growth at 37°C, but sec34
s35 double mutants are inviable at 24°C (VanRheenen et
al., 1999
). We found that sec36-1 was also
synthetically lethal at 24°C with both the sec34-2 and
sec35-1 mutations (Figure 7D). A new allele of
SEC34, sec34-3, was obtained from another mutant
recovered through the ribosome synthesis screen (strain 394ts; see
MATERIALS AND METHODS). We found that sec36-1 was
synthetically lethal with this novel allele as well (Figure 7D).
Together, these data demonstrate that a close physical and functional
relationship exists between Sec34p, Sec35p, and Sec36p.
Proteins Likely to be Components of Sec34p/Sec35p Complex Coimmunoprecipitate with Sec36p Antibody
Knowing that Sec36p is in the complex that contains Sec34p and
Sec35p, we evaluated whether other components of this complex may
associate with Sec36p as well. Accordingly, we found that affinity-purified Sec36p antibody immunoprecipitated a series of
protein bands with apparent molecular masses of 35 kDa (p35), 51 kDa
(p51), 70 kDa (p70), 100 kDa (p100), and 105 kDa (p105) (Figure
8A). These bands were not present in
control immunoprecipitates with sec36-1 mutant extracts
(Figure 8A), or immunoprecipitations with extracts from
sec36::kanMX6 strains containing
SLY1-20 (our unpublished data). Therefore, they likely
represented Sec36p and proteins that specifically interact with
full-length Sec36p.
|
After Sec36p antibody immunoprecipitates from wild-type cells were washed with 0.2% SDS or 2 M urea, only p51 remained tightly associated with the antibody (Figure 8A), indicating that this species was Sec36p itself, consistent with the predicted size for Sec36p of 48 kDa. A 30-kDa band (p30) was observed in immunoprecipitations from a sec36-1 mutant that was not present in immunoprecipitations from wild-type lysates (Figure 8A). This band probably corresponds to the truncated protein produced by the sec36-1 mutation.
The remaining p105, p100, p70, and p35 protein bands were likely to be
proteins that associate with Sec36p. Because Sec34p-myc and
Sec35p-myc both efficiently immunoprecipitated Sec36p, it was reasonable that Sec36p antibody coimmunoprecipitated Sec34p and
Sec35p. Sec34p migrates at 105 kDa by SDS-PAGE (Kim et al., 1999
), so it was likely that the p105 band was Sec34p. The predicted molecular mass of Sec35p is ~32 kDa, so the p35 band was likely to be
Sec35p. It was unlikely that the p70 and p100 bands were fragments of
Sec34p because significant degradation of endogenous Sec34p had not
been observed by immunoblotting with Sec34p polyclonal antibody (our unpublished data). Therefore, these species probably represented previously uncharacterized components of the
Sec34p/Sec35p/s36p complex. Initial efforts to obtain enough material
to identify these additional proteins by mass spectrometry from
complexes isolated by affinity chromatography on a Sec36p antibody
column, or using Sec36p tagged with glutathione
S-transferase, were unsuccessful (our unpublished data).
Proteins Encoded by ORFs YNL041c and YPR105c Coimmunoprecipitate with Sec35p-myc
To identify additional components of the Sec34p/Sec35p/s36p complex, we next performed large-scale c-myc antibody (9E10) immunoprecipitations with extracts from cells overexpressing Sec35p-myc. In these experiments, several protein bands (p70, p90, p95, and p100) seemed to specifically coimmunoprecipitate with Sec35p-myc, indicated as p45 (Figure 8B). Other Sec35p-myc-interacting proteins may have been missed in our analysis because we used strains expressing abnormally high levels of Sec35p-myc. For example, endogenous Sec36p was also coimmunoprecipitated with Sec35p-myc in these experiments, as detected by immunoblotting with Sec36p antibody (our unpublished data), but a significant Coomassie-stained protein band around the size of endogenous Sec36p was not observed in elution fractions (Figure 8B).
All four of the protein bands that specifically coimmunoprecipitated in
our experiments were digested with trypsin, and analyzed by
matrix-assisted laser desorption ionization mass spectrometry. The set
of peptides in which mass-to-charge (m/z) values were >1000
were used to identify the proteins contained in these samples (Table
3). At a mass tolerance of ±25 parts per
million (ppm), 10/35 peptides from the p100 band matched the
YPR105c-encoded protein, and a nonoverlapping set of 15/35 peptides
from the p100 band matched the YNL041c-encoded protein. No matches were
found for the p90 and p95 fragments even when the mass tolerance was increased to ±50 ppm, so the proteins contained in these two band remain unidentified. At a mass tolerance of ±50 ppm, 11/20 peptides from the p70 band matched the YPR105c-encoded protein. To demonstrate the significance of this result, the region corresponding to the p70
fragment from the immunoprecipitation lacking Sec35p-myc was also analyzed by mass spectrometry. It yielded no matches, even with a
higher mass tolerance window.
|
Based on their predicted amino acid sequences, the YNL041c- and YPR105c-encoded proteins are estimated to be 97 and 99 kDa, respectively (Saccharomyces Genome Database, Stanford University, Stanford, CA). It was, therefore, likely that the 100-kDa band contained a mixture of these proteins, and that the 70-kDa band was a degradation product of the YPR105c-encoded protein.
Importantly, results from recent large-scale yeast two-hybrid screens
show that the YNL041c-encoded protein interacts with both Sec35p and
Sec36p, and that the YPR105c-encoded protein interacts with Sec35p
(Uetz et al., 2000
; Ito et al., 2001
). These
interactions strongly suggest that both YNL041c and YPR105c encode
proteins that physically associate with Sec34p, Sec35p, and Sec36p.
Consequently, we have designated YNL041c and YPR105c as
SEC37 and SEC38, respectively.
SEC37 and SEC38 Encode Conserved Proteins
Both SEC37 and SEC38 encode proteins that
are probably cytosolic or peripherally associated with membranes,
because their predicted sequences lacked obvious transmembrane domains.
Sec37p and Sec38p share significant amino acid sequence similarity
along their lengths with predicted proteins from other budding yeast species (http://cbi.labri.u-bordeaux.fr/Genolevures/Genolevures.php3) as well as from other eukaryotes (Table
4). Therefore, Sec37p and Sec38p seem to
be highly conserved eukaryotic proteins. For Sec38p, the
Arabidopsis thaliana homolog is distinguished from the
others by the presence of an N-terminal extension (Table 4). For
Sec37p, the S. cerevisiae protein is longer than related
proteins from other species, primarily due to a 100-200-amino acid
extension at the N terminus (Table 4).
|
Disruption of SEC37 Produces Defects Similar to Those Caused by Mutations in SEC34 and SEC35
We found that haploid cells in which the SEC37 was replaced with kanMX4 grew on complete medium at temperatures ranging from 24 to 37°C (our unpublished data). Therefore, SEC37 was apparently dispensable for robust growth at physiological temperatures.
To test whether sec37::kanMX4 cells have any
defect in vesicle-mediated transport, we monitored the transport of CPY
through the secretory pathway by pulse-labeling and
immunoprecipitation. In wild-type cells, CPY was efficiently processed
to its mature form after 1 min, whereas in the
sec37::kanMX4 strain, CPY was delayed in its
conversion from the ER-modified p1 form to the Golgi-modified p2 form
(Figure 9A). The p1 form of CPY was
previously shown to accumulate in ER-to-Golgi secretory pathway
mutants, including strains containing mutations in SEC34 or
SEC35 (Li and Warner, 1996
; Wuestehube et al.,
1996
).
|
For evidence that disruption of SEC37 specifically affected the complex that contains Sec34p and Sec35p, a sec37::kanMX4 halpoid strain was crossed to strains containing sec34-2, sec35-1, and sec36-1 alleles. As shown in Figure 9B, deletion of SEC37 was synthetically lethal at 24°C with sec34-2 and sec35-1, but not with sec36-1.
SEC38 Is Essential and Displays Genetic Interactions Consistent with a Functional Link to SEC34 and SEC35
Haploid cells in which SEC38 was replaced by
kanMX4 were inviable at 24°C, and could not form visible
microcolonies (Figure 10A). However, in
the presence of the SLY1-20 plasmid, these
sec38::kanMX4 cells formed visible microcolonies
(Figure 10A). Previous results have implied that the ability to be
suppressed by SLY1-20 is a hallmark of mutations in genes
that encode proteins with functions related to Sec34p and Sec35p
function (VanRheenen et al., 1998
, 1999
; Figure 7).
Therefore, this result suggests that the function of Sec38p is related
to that of Sec34p and Sec35p. Likewise, it was observed previously that
overexpression of Sec34p, Sec35p, or Sec36p, suppressed the
temperature-dependent growth defects of a sec35-1 mutant
strain at 33°C, and we found that overexpression of Sec38p has a
similar effect (VanRheenen et al., 1998
, 1999
; Figures 7C
and 10B). Collectively, these results support a functional as well as
physical connection between Sec38p and Sec34p, Sec35p, and Sec36p. Our
results are consistent with those published elsewhere during submission
of this article, in which Sec38p/Sgf1p was isolated as a high-copy
suppressor of the temperature sensitivity of sec35-1 that
interacts with Sec35p and cofractionates with Sec34p and Sec35p (Kim
et al., 2001
).
|
Disruption of SEC37 or SEC38 Affects Size of Complex Containing Sec34p and Sec35p
To determine how Sec37p and Sec38p might influence the complex
that contains Sec34p and Sec35p, extracts from cells containing either
SEC37 disrupted with kanMX4 or SEC38
disrupted with kanMX4 were fractionated on a Superose 6 gel
filtration column. When sec37::kanMX4 cell
extracts were fractionated this way, Sec34p, Sec35p, and Sec36p still
comigrated through the column, but were slightly delayed relative to
their migration during fractionation of wild-type extracts (Figure
11), implying that deletion of Sec37p results in a partial disruption of the complex (Table
5).
|
|
Because SEC38 is essential, to analyze the effects of
deleting SEC38, we used a sec38::kanMX4
strain containing the SLY1-20 plasmid. We found that the
SLY1-20 plasmid did not affect the elution of Sec34p or
Sec35p from the Superose 6 column (Figure 12A). Disruption of SEC38,
however, had a dramatic effect on the migration of Sec34p and Sec35p
from the column (Figure 12B). These two proteins no longer coeluted and
were largely distributed to distinct fractions. This result suggests
that Sec38p may be necessary for Sec34p and Sec35p to interact, as well
as for the integrity of the complex as a whole. This may be why
disruption of SEC38 had such a drastic effect on cell
viability. Conversely, the more subtle effects that loss of
SEC37 has on the complex may explain why disrupting that
gene did not cause a significant growth defect.
|
Evidence That Cod4p, Cod5p, and Dor1p Function in Sec34p/Sec35p Complex In Vivo
While this article was in preparation, Whyte and Munro (2001)
reported isolation of a complex containing the proteins Cod4p, Cod5p,
and Dor1p in addition to the five subunits of Sec34p/Sec35p complex
that we have described herein. We were interested, therefore, to extend
our genetic and biochemical analyses to these three additional gene
products. We first tested disruption of COD4, COD5, and DOR1 for their effects on cell
viability and protein transport. Although strains containing
cod4::kanMX4, cod5::kanMX4, and dor1::kanMX4 alleles display wild-type growth
at a range of temperatures, we found that each of these mutations
causes a severe synthetic growth defect in combination with the
sec35-1 allele at 24°C (Figure
13A). A strain carrying
dor1::kanMX4 displayed the most severe synthetic
growth defect, and also displayed a significant delay in the maturation
of CPY from p1 (ER form) to p2 (Golgi form) (Figure 13B).
|
To test the effect of these alterations on the complex that contains the majority of Sec34p and Sec35p, we prepared cytosol from each disruption strain and determined the size of the Sec34p/Sec35p complex by gel filtration. All three deletions caused a slight shift in the mobility of Sec34p and Sec35p that was similar to that observed when SEC37 was deleted (compare Figure 13C with Figure 11).
| |
DISCUSSION |
|---|
|
|
|---|
Identification of Proteins in a Complex with Sec34p and Sec35p
Our investigation began with the identification of
sec36-1, a conditional mutation in a new secretion gene.
Examination of Sec36p revealed that it binds to Sec34p and Sec35p, two
genes that have been shown recently to be part of a large complex
required for transport of proteins through early steps in the secretory pathway (VanRheenen et al., 1998
, 1999
; Kim et
al., 1999
). A parallel evaluation of mutations in
SEC34, SEC35, and SEC36 revealed that 1) missense mutations in SEC34, SEC35, and
SEC36 are synthetically lethal with one another; 2) these
missense alleles cause a pleiotropic block in protein trafficking at
either the ER or Golgi stage of the secretory pathway; 3) disruption of
any one of these genes results in a severe growth defect that can be
partially suppressed by the SLY1-20 allele; and 4)
overexpression of Sec34p or Sec36p partially suppresses the
temperature-dependent growth defects caused by the sec35-1
mutation. Together, these genetic observations indicate that Sec34p,
Sec35p, and Sec36p function together in a common process necessary for
protein trafficking in the early part of the secretory pathway.
Affinity isolation of protein complexes containing Sec35p had
previously revealed a set of copurifying polypeptides (Kim et al., 1999
). We found an overlapping set of protein bands after affinity isolation of Sec36p, reinforcing the idea that the native Sec34p/Sec35p complex contains a number of protein species in addition
to Sec34p, Sec35p, and Sec36p. By using mass spectrometry we identified
two additional proteins present in affinity-isolated complexes, which
we designate Sec37p and Sec38p. Both Sec37p and Sec38p associate with
the Sec34p/Sec35p complex as shown by coimmunoprecipitation experiments
and yeast two-hybrid interactions. Disruption of SEC38 is
lethal, but can be partially suppressed by a SLY1-20
mutation. Moreover, overexpression of SEC38 can suppress
growth defects caused by the sec35-1 mutation. Disruption of
SEC37 alone has little effect on cell growth, but a deletion
of SEC37 is synthetically lethal with sec34 and
sec35 missense mutations. These genetic interactions
indicate that both SEC37 and SEC38 contribute to the in vivo function of the Sec34p/Sec35p complex.
Proteins That Comprise Core of Sec34p/Sec35p Complex
Most of the Sec34p, Sec35p, and Sec36p proteins are in the cytosolic fraction of yeast cell lysates. Gel filtration of cytosol shows that all three proteins cofractionate as a large complex with an estimated mass of >800 kDa. Because gel filtration seemed to be a more gentle fractionation procedure than affinity isolation, which includes potentially disruptive washing steps, we have used gel filtration of crude cytosolic extracts as a way to compare the structure of the Sec34p/s35p complex in different mutants. By this assay, mutations in SEC35, SEC36, and SEC38 cause a dramatic effect on the size of native complex as shown by the redistribution of other proteins in the complex to low molecular weight fractions.
Thus, mutations in SEC34, SEC35, SEC36, and SEC38 are similar in that they are either lethal or greatly compromise cell growth, they result in a pronounced defect in transport of CPY through the early stages of the secretory pathway, and they disrupt the integrity of the Sec34p/Sec35p complex. We therefore propose that these four proteins comprise a functional core of the Sec34p/Sec35p complex.
Multiple components of the Sec34p/Sec35p complex seem to be conserved
among eukaryotic species, indicating that a homolog of the complex
exists in metazoans as well as in yeast (Suvorova et al.,
2001
; Whyte and Munro, 2001
). It is therefore surprising that among the
four genes that we have found to be the most important for the function
and integrity of the Sec34p/Sec35p complex, Sec35p and Sec36p seem to
be present only in yeast species. It seems possible that the
counterparts of the Sec34p/Sec35p complex in metazoans contain proteins
that perform the same function as Sec35p and Sec36p without sharing
obvious sequence similarity.
Peripheral Components of Sec34p/Sec35p Complex
Deletion of SEC37 does not interfere with cell growth
and only causes a small delay in the processing of CPY. Consistent with the relatively minor phenotypic effects of a sec37
mutation, extracts prepared from this deletion strain revealed a
relatively small alteration in the mobility of the Sec34p/Sec35p
complex. Although changes in mass of a large protein complex can only
crudely be approximated by gel filtration, the change in mobility
caused by sec37
is consistent with the absence of only
the ~100-kDa Sec37p protein itself and does not give any indication
that association of the core proteins has been affected. Thus, Sec37p
seems to be peripherally associated with the complex and to not be
required for its essential cellular function.
Recently, Whyte and Munro (2001)
reported the affinity isolation of
eight different proteins, including Sec34p and Sec35p, by their
association with Dor1p, a protein involved in Golgi function. Three of
these proteins, Dor1p, Cod4p, and Cod5p, were not among the components
that copurified with Sec35p-myc that we were able to identify by mass
spectroscopy. However, two proteins bands that sometimes
coimmunoprecipitated with Sec36p in our experiments (Figure 8A,
asterisks), migrate at positions consistent with Dor1p (70 kDa, upper
asterisk), and Cod4p or Cod5p (46 or 32 kDa, lower asterisk). We are
not sure whether we did not identify Dor1p, Cod4p, or Cod5p in our mass
spectroscopic analysis because the form of the complex that we isolated
using Sec35p-myc has a different subunit composition than
the complex isolated by association with Dor1p-protein A, or because
some of the polypeptides in the complex had dissociated or were
degraded during the affinity isolation. Nevertheless, we were
interested in applying our gel filtration assay to mutants in these
additional genes to ascertain their effect on the Sec34p/Sec35p
complex. Extracts from strains carrying cod4
,
cod5
, or dor1
revealed relatively small
differences in the elution of the Sec34p/Sec35p complex, similar to
those observed for sec37
. Phenotypic tests of
cod4
, cod5
, and dor1
strains revealed no
impairment of growth and only very minor defects in CPY maturation. We
therefore tentatively conclude that Cod4p, Cod5p, and Dor1p are also
peripheral components of the Sec34p/Sec35p complex. We were interested
to know whether the cytosolic form of the Sec34p/Sec35p complex has a
homogenous structure comprised of all eight identified proteins or
whether different subcomplexes might exist. Unfortunately, the shift in
elution volume caused by deletion of any of the four peripheral
components (Sec37p, Cod4p, Cod5p, or Dor1p) is too small relative to
the dispersion of the complex during gel filtration to judge whether
isoforms of the complex lacking one or more peripheral proteins might
exist in a wild-type cytosolic fraction.
Possible Cellular Functions of Sec34p/Sec35p Complex
Two lines of evidence have suggested a role for the Sec34p/s35p
complex in transport vesicle tethering with the cis-Golgi or
some other Golgi compartment. First, in a reconstituted assay for
transport between the ER and Golgi, extracts from sec34-2 and sec35-1 mutants displayed defects in the attachment of
ER-derived vesicles to Golgi membranes (VanRheenen et al.,
1998
, 1999
). Second, sequence similarities have been detected between
two components of the Sec34p/s35p complex (Dor1p and Sec34p) and
components of the exocyst complex (Sec5p and Exo70p), which is required
for tethering of post-Golgi secretory vesicles with the plasma membrane (TerBush et al., 1996
; Whyte and Munro, 2001
). However, we
believe that the assignment of a vesicle tethering function to the
Sec34p/Sec35p complex remains tenuous for the following reasons. First,
the in vitro assays that revealed a tethering defect in
sec34 and sec35 mutants used membrane and
cytosolic fractions derived from mutant cells that had been incubated
at the restrictive temperature for several hours (VanRheenen et
al., 1998
, 1999
). Thus, it is quite possible that the observed
tethering defect could have been a secondary consequence of defective
Golgi organization in the cells from which the constituents for the in
vitro reaction were derived. Moreover, analysis of sec36-1
mutants revealed no transport defect for any of the steps in
ER-to-Golgi transport, including vesicle tethering, by an assay of the
in vitro transport activity of extracts that had been incubated at the
restrictive temperature (Barlowe, personal communication). Finally, the
observed sequence similarities to tethering complex proteins do not
necessarily imply a conserved function. Dor1p does show clear sequence
similarity to Sec5p, but the reported similarities between Sec34p and
Exo70p are of uncertain functional significance (identification of
these alignments requires multiple iterations of PSI-BLAST searches). Therefore, it seems premature to conclude that the Sec34p/Sec35p complex performs the same basic function as the exocyst, given the
rather limited extent of sequence alignment between these two very
large complexes.
A key limitation in our knowledge of the Sec34p/Sec35p complex that has hindered a more precise definition of its molecular function, is that the steps in the secretory pathway that